Welcome, how can we help?
Home Chevron
Sitemap Chevron
Quick Quote Chevron
Different types of insurance Chevron
Life insurance companies Chevron
Life insurance or life assurance? Chevron
Who can I buy life insurance from? Chevron
Policy Types
Critical illness cover Chevron
Family income benefit life insurance Chevron
Income protection insurance Chevron
Level term life insurance
Mortgage protection life insurance Chevron
Mortgage payment protection Chevron
Terminal illness cover Chevron
Total permanent disability
Unemployment insurance Chevron
Waiver of premium
Getting Technical
Childrens critical illness cover Chevron
Legal principles of life insurance Chevron
Living outside the uk
Reviewable vs Guaranteed premiums
Who regulates us? Chevron
Will I get a critical illness? Chevron

 

Home / News / New drug could improve Parkinson's

New drug could improve Parkinson's


11 June 2007 15:51:48



The motor functions and cognitive abilities by Parkinson's disease could be combated by a new drug, according to pharmaceutical analysts.

Research presented at the 59th annual meeting of the American Academy of Neurology presented the findings of a six-month trial of safinamide.

Participants were divided into randomised, double-blind and placebo controlled categories of administering of the drug, with the results showing a potential breakthrough for fighting the debilitating symptoms of Parkinson's disease.

Motor symptoms were found to be markedly improved in the study, while the addition of safinamide to a single dopamine dosage led to a notable change in 'executive function', i.e. a patient's ability to plan, organise and remember details.

Professor Anthony Schapira, chairman of the University Department of Clinical Neuroscience at Royal Free and University College London Medical School, said:

"These study results suggest that safinamide may have an effect on cognitive performance in patients with early Parkinson's disease and has the potential to address a critical unmet medical need."

Though commonly associated with the elderly, between five to ten per cent of Parkinson's disease incidence occurs in people under 40.ADNFCR-980-ID-18175996-ADNFCR
News Archive

August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007